Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia

被引：0

作者：

Lachowiez, Curtis ^{[1
]}

Takahashi, Koichi ^{[2
]}

Loghavi, Sanam ^{[3
]}

Xiao, Lianchun ^{[4
]}

Kadia, Tapan ^{[2
]}

Adeoti, Maria ^{[2
]}

Short, Nicholas ^{[2
]}

Sasaki, Koji ^{[2
]}

Wang, Sa ^{[3
]}

Borthakur, Gautam ^{[2
]}

Issa, Ghayas ^{[2
]}

Maiti, Abhishek ^{[2
]}

Alvarado, Yesid ^{[2
]}

Pemmaraju, Naveen ^{[2
]}

Bravo, Guillermo Montalban ^{[2
]}

Masarova, Lucia ^{[2
]}

Yilmaz, Musa ^{[2
]}

Jain, Nitin ^{[2
]}

Andreeff, Michael ^{[2
]}

Jabbour, Elias ^{[2
]}

Garcia-Manero, Guillermo ^{[2
]}

Kornblau, Steven ^{[2
]}

Ravandi, Farhad ^{[2
]}

Konopleva, Marina ^{[2
]}

Kantarjian, Hagop ^{[2
]}

DiNardo, Courtney ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

induction chemotherapy; venetoclax; targeted therapy; acute myeloid leukemia;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-204

引用

页码：S291 / S291

页数：1

共 50 条

[31] Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
Zhang, Baohang
Liu, Qingguo
Li, Junfan
Hu, Yimin
Zhao, Xin
Huang, Pingping
Li, Shangzhu
Wang, Ying
FRONTIERS IN ONCOLOGY, 2023, 13
[32] The propriety of upgrading responses to venetoclax plus azacitidine in newly diagnosed patients with acute myeloid leukemia
Abbott, Diana
Cherry, Evan
Amaya, Maria
McMahon, Christine
Schwartz, Marc
Winters, Amanda
Schowinsky, Jeffrey
Jordan, Craig T.
Smith, Clayton
Gutman, Jonathan A.
Pollyea, Daniel A.
LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1466 - 1473
[33] Venetoclax in Acute Myeloid Leukemia
Mihaila, Romeo G.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
[34] Limited Toxicity and Impressive Outcomes of Upfront Flag-Based Induction in Newly Diagnosed Acute Myeloid Leukemia: An Indian Scenario
Soni, Mayank
Rainchwar, Sujay
Shaikh, Mohd Rizwan
Singh, Reema
Sheth, Vipul
Panda, Tribikram
Halder, Rohan
Palatty, Roy J.
Agrawal, Narendra
Senapati, Jayastu
Bhurani, Dinesh
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S331 - S331
[35] Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis
Wang, Rong
Zhang, Yi
Chang, Jie
Wang, Huafeng
Lou, Yinjun
Yang, Min
Xu, Gaixiang
Tong, Hongyan
Xie, Wanzhuo
Zhou, De
Wei, Juying
Mai, Wenyuan
Ye, Xiujin
Meng, Haitao
Jin, Jie
Zhu, Hong-Hu
HEMATOLOGICAL ONCOLOGY, 2024, 42 (02)
[36] Safety and Efficacy of FLAG-IDA-Based Therapy Combined With Venetoclax for the Treatment of Newly Diagnosed and Relapsed/Refractory Patients With AML: A Systematic Review
Sherban, Adi
Fredman, Danielle
Shimony, Shai
Yeshurun, Moshe
Raanani, Pia
Stahl, Maximillian
Gafter-Gvili, Anat
Wolach, Ofir
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S264 - S264
[37] Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
Liang, Peiqi
Xie, Yan
Liu, Ziyi
Wang, Dong
Li, Qian
Lu, Yin
Xue, Shengli
Wang, Ying
Chen, Suning
Wu, Deipei
Fu, Jianhong
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1219 - 1226
[38] Venetoclax Resistance in Acute Myeloid Leukemia
Garciaz, Sylvain
Hospital, Marie-Anne
Collette, Yves
Vey, Norbert
CANCERS, 2024, 16 (06)
[39] Venetoclax in adult acute myeloid leukemia
Hu, Mengci
Li, Wenzhe
Zhang, Youshan
Liang, Caixia
Tan, Jie
Wang, Ya
BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
[40] A Single-Center Comparison of Decitabine ± Venetoclax or FLAG in the Treatment of Secondary Acute Myeloid Leukemia
Stonerock, Devon
Homan, Morgan
Marini, Bernard
Perissinotti, Anthony
Bixby, Dale
Burke, Patrick
Pettit, Kristen
Benitez, Lydia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S210 - S210

← 1 2 3 4 5 →